Oral Tranexamic Acid and Topical Hydroquinone in the Treatment of Melasma

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 16, 2016

Primary Completion Date

April 2, 2017

Study Completion Date

April 2, 2017

Conditions

Melasma

Interventions

DRUG

Tranexamic Acid Oral Product

Encapsulated tranexamic acid 250 mg

DRUG

Hydroquinone 4% Cream

OTHER

Sunscreen

Sunscreen SPF 30

DEVICE

Placebo

Encapsulated placebo

All Listed Sponsors

lead

Fakultas Kedokteran Universitas Indonesia

OTHER

NCT03751163 - Oral Tranexamic Acid and Topical Hydroquinone in the Treatment of Melasma | Biotech Hunter | Biotech Hunter